Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
2.
Am J Transplant ; 6(5 Pt 2): 1212-27, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16613597

RESUMO

This article reviews the development of the new U.S. lung allocation system that took effect in spring 2005. In 1998, the Health Resources and Services Administration of the U.S. Department of Health and Human Services published the Organ Procurement and Transplantation Network (OPTN) Final Rule. Under the rule, which became effective in 2000, the OPTN had to demonstrate that existing allocation policies met certain conditions or change the policies to meet a range of criteria, including broader geographic sharing of organs, reducing the use of waiting time as an allocation criterion and creating equitable organ allocation systems using objective medical criteria and medical urgency to allocate donor organs for transplant. This mandate resulted in reviews of all organ allocation policies, and led to the creation of the Lung Allocation Subcommittee of the OPTN Thoracic Organ Transplantation Committee. This paper reviews the deliberations of the Subcommittee in identifying priorities for a new lung allocation system, the analyses undertaken by the OPTN and the Scientific Registry for Transplant Recipients and the evolution of a new lung allocation system that ranks candidates for lungs based on a Lung Allocation Score, incorporating waiting list and posttransplant survival probabilities.


Assuntos
Alocação de Recursos para a Atenção à Saúde/métodos , Transplante de Pulmão/métodos , Obtenção de Tecidos e Órgãos/métodos , Adolescente , Adulto , Idoso , Criança , Doação Dirigida de Tecido , Sobrevivência de Enxerto , Humanos , Pessoa de Meia-Idade , Alocação de Recursos , Estados Unidos , Listas de Espera
4.
J Heart Lung Transplant ; 13(1 Pt 1): 15-21; discussion 22-3, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7513185

RESUMO

As lung transplantation has become more successful, the selection criteria have broadened; however, some relative contraindications to lung transplantation are controversial. Some programs consider mechanical ventilation to be a major contraindication to lung transplantation because airway colonization with bacteria may lead to nosocomial infection and respiratory muscle deconditioning may necessitate prolonged postoperative ventilatory support. We report our experience of seven double lung transplant procedures on six patients requiring mechanical ventilation. Five patients with cystic fibrosis required preoperative mechanical ventilation for 7 to 19 days (mean, 10.7 days). One patient with acute lung injury required 115 days of preoperative mechanical ventilatory support. Only the latter patient required prolonged (27 days) postoperative mechanical ventilation because of respiratory muscle weakness; the others were extubated in 1 to 19 days (mean, 7.8 days). No early complications related to bacterial infection were seen. Two patients required temporary hemodialysis for transient kidney failure. Three patients had postoperative neurologic residua; one patient had a transient hemiparesis, and seizures developed in two patients. One patient died 3 months after transplantation from severe central nervous system complications with no evidence of pulmonary problems; and two patients died 17 months after transplantation, one of them receiving a second double lung transplant for obliterative bronchiolitis. Except for the patient who required prolonged preoperative ventilatory support, mechanical ventilation did not appear to play a role in the outcome of these patients. The posttransplantation hospital stay and hospital charges for patients requiring pretransplantation ventilatory support were not significantly different from those for other lung transplant recipients.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Transplante de Pulmão , Respiração Artificial , Adolescente , Adulto , Bronquiolite Obliterante/cirurgia , Bronquiolite Obliterante/terapia , Burkholderia cepacia , Causas de Morte , Fibrose Cística/microbiologia , Fibrose Cística/cirurgia , Fibrose Cística/terapia , Feminino , Humanos , Tempo de Internação , Transplante de Pulmão/reabilitação , Masculino , Cuidados Pré-Operatórios/economia , Infecções por Pseudomonas/terapia , Pseudomonas aeruginosa , Respiração Artificial/economia , Síndrome do Desconforto Respiratório/cirurgia , Síndrome do Desconforto Respiratório/terapia , Insuficiência Respiratória/terapia , Paralisia Respiratória/terapia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA